Atrial fibrillation

Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.

A treatment for an incurable cancer. Catheters to better diagnose and treat AFib. A surgical stapler that’s easier to use. These are just some of the Johnson & Johnson advances that are helping improve the health of people everywhere.

More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. Learn the facts behind this heart condition, plus one patient’s diagnosis story.

Hidden in large amounts of digital information—such as anonymized medical records—may be the keys to transforming the future of healthcare. Troy C. Sarich, Ph.D., Johnson & Johnson’s Chief Commercial Data Science Officer, shares how the company is carefully collecting, analyzing and harnessing this information to improve the health of people everywhere.

Some 33 million people worldwide have atrial fibrillation, a form of heart disease that can lead to stroke. Are you at risk? For AFib Awareness Month, take this quiz to test your AFib know-how.

Cardiologist C. Michael Gibson is heading up a virtual research study that uses wearable technology and cutting-edge apps to help detect atrial fibrillation, one of the biggest risk factors for stroke. We dive into how the study will work.